|
| 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline Basic information |
Product Name: | 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline | Synonyms: | [2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine;2-Methoxy-4-(4-(4-Methylpiperazin-1-yl)piperidin-1-yl)benzenaMine;2-Methoxy-4-[4-(4-Methyl-1-piperazinyl)-1-piperidinyl]-BenzenaMine;2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilin;[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine,761440-75-9;[2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine ISO 9001:2015 REACH;Benzenamine, 2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]-;WDQZQPCYVLHWRA | CAS: | 761440-75-9 | MF: | C17H28N4O | MW: | 304.43 | EINECS: | 1592732-453-0 | Product Categories: | 761440-75-9 | Mol File: | 761440-75-9.mol | |
| 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline Chemical Properties |
Boiling point | 479.3±45.0 °C(Predicted) | density | 1.126±0.06 g/cm3(Predicted) | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | pka | 8.14±0.42(Predicted) | InChI | InChI=1S/C17H28N4O/c1-19-9-11-21(12-10-19)14-5-7-20(8-6-14)15-3-4-16(18)17(13-15)22-2/h3-4,13-14H,5-12,18H2,1-2H3 | InChIKey | WDQZQPCYVLHWRA-UHFFFAOYSA-N | SMILES | C1(N)=CC=C(N2CCC(N3CCN(C)CC3)CC2)C=C1OC |
| 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline Usage And Synthesis |
Uses | [2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amine is an intermediate of Brigatinib which is a medicine used to treat cancer that suppresses epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). |
| 2-Methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]aniline Preparation Products And Raw materials |
|